Indefinite Delivery Contract 75N93023D00017
Award Date
6/20/23
Last Date to Order
6/19/30
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Mriglobal
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The $40 million IDC, titled "Pre-Clinical Models of Infectious Diseases", has an ultimate completion date of July 13, 2024 and is part of the larger NIAID Preclinical Models of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Resourcepath, LLC, a certified Woman-Owned Small Business, to provide a comprehensive array of diagnostic pre-clinical services. The $12 million DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM IDIQ contract has a 7-year ordering period through June 2030. Under this contract, Resourcepath...
This indefinite delivery contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Midwest Research Institute (doing business as Mriglobal) aims to provide pre-clinical evaluation of infectious disease countermeasures. The $146.3 million single-award IDC has a period of performance through August 2024. The contract covers the development and refinement of small animal, non-human primate, and animal replacement/non-traditional models to...
The National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to Mriglobal, doing business as Midwest Research Institute, with a potential value of $545,452,906 and period of performance from September 1, 2021 through August 31, 2028. The contract provides comprehensive and rapid response services to support NIAID's research programs including clinical trials, manufacturing, nonclinical studies, analytics, and basic research. A $2,000 firm fixed...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH-NIAID) has awarded a $36 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the Diagnostic Pre-Clinical Services Program to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. Under this single-award IDIQ contract, Dynport will provide a wide range of services to support the development of in vitro diagnostic products for the...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded multiple Indefinite Delivery/Indefinite Quantity contracts with a total potential value of $364,553,934 to support preclinical and translational vaccine development services. Task areas under the contracts include product storage and shipping, safety and immunogenicity studies, feasibility assessments, analytical development, process development, cGMP manufacturing, stability testing, fill-finish, and...
This is a single-award Indefinite Delivery Contract issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit organization that manufactures biologics. The Diagnostics Pre-Clinical Services Program IDIQ contract has a potential value of $24,000,000 over a 7-year ordering period ending June 2030. Under this contract, ABL will provide a broad range of preclinical diagnostic...
This federal Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $49,990,000 single-award IDC has an ultimate completion date of June 30, 2028 and does not have a set-aside designation. Under this IDC, Mriglobal is providing a range of scientific research, testing, and product...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75N93023D00017-75N93023F00002 | Mriglobal | $3.5k | 6/20/23 | 6/19/30 | 7/5/23 | |
Delivery Order 75N93023D00017-75N93023F00001 | Mriglobal | $3.5k | 6/20/23 | 6/19/30 | 7/10/23 |